Sowell Financial Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,465
Closed -$399K 775
2021
Q1
$399K Buy
1,465
+359
+32% +$96.8K 0.01% 727
2020
Q4
$271K Sell
1,106
-3,410
-76% -$880K 0.01% 736
2020
Q3
$1.28M Buy
4,516
+941
+26% +$262K 0.06% 248
2020
Q2
$956K Buy
3,575
+2,678
+299% +$805K 0.05% 284
2020
Q1
$284K Sell
897
-1,517
-63% -$460K 0.02% 562
2019
Q4
$716K Buy
2,414
+1,235
+105% +$343K 0.05% 344
2019
Q3
$274K Buy
+1,179
New +$275K 0.02% 557
2019
Q1
$558K Buy
+2,359
New +$743K 0.06% 298
2018
Q4
Sell
-879
Closed -$311K 467
2018
Q3
$311K Buy
879
+25
+3% +$8.61K 0.05% 264
2018
Q2
$291K Buy
854
+89
+12% +$25K 0.06% 227
2018
Q1
$210K Sell
765
-23
-3% -$7.14K 0.05% 249
2017
Q4
$271K Buy
788
+5
+0.6% +$1.6K 0.07% 222
2017
Q3
$247K Buy
783
+1
+0.1% +$296 0.06% 216
2017
Q2
$226K Buy
+782
New +$207K 0.06% 223
2017
Q1
Sell
-772
Closed -$220K 286
2016
Q4
$220K Buy
+772
New +$229K 0.07% 179

Other funds holding BIIB

Sowell Financial Services's BIIB Position: Q2 2021 in Review

Sowell Financial Services sold out of Biogen (BIIB) in Q2 2021, closing a stake of 1,465 shares — an estimated $399K sold.

Sowell Financial Services first reported a position in BIIB in Q4 2016 and held it in 15 quarters. The position peaked at $1.28M in Q3 2020. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • Sowell Financial Services reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,465 Biogen shares in Q2 2021, an estimated $399K.
  • Sowell Financial Services first reported a position in Biogen in Q4 2016 and held it in 15 quarters.
  • Sowell Financial Services's Biogen position peaked at $1.28M in Q3 2020.
  • 1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.